Meta-analysis: mortality and serious adverse events of peginterferon plus ribavirin therapy for chronic hepatitis C.
about
Diabetes and Hepatitis C: A Two-Way Association.Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study.Interferon-free regimens for hepatitis C: combine and conquer.Hepatitis C Genotype Prevalence in Monastir Region, Tunisia: Correlation between 5' Untranslated Region (5'UTR), Non-structural 5B (NS5B), and Core Sequences in HCV Subtyping.MHC class I-related chain B gene polymorphism is associated with virological response to pegylated interferon plus ribavirin therapy in patients with chronic hepatitis C infection.Efficacy and safety of interferon treatment in elderly patients with chronic hepatitis C in Japan: A retrospective study using the Japanese Interferon Database.Peg-interferon and ribavirin treatment in HIV/HCV co-infected patients in Thailand: efficacy, safety and pharmacokinetics.
P2860
Q36056076-6059986D-3A00-40C7-A354-0BAE0BD09D2EQ37636210-A38E052F-E300-4FBF-AC0C-C4999055A497Q38156403-F87F88F4-BFE5-41BF-9200-7B24BA65ABF6Q38866070-A387E5F1-59BE-4B8A-B568-851C6770DD2FQ41161023-C1196ABA-0A1F-4B2D-BF29-C39612048ACFQ41750179-C71ADA79-57E7-49E8-8363-9CD5C857ECF5Q47564858-B49CDF3D-B6B5-4C5E-9B74-5C00E937A587
P2860
Meta-analysis: mortality and serious adverse events of peginterferon plus ribavirin therapy for chronic hepatitis C.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Meta-analysis: mortality and s ...... erapy for chronic hepatitis C.
@ast
Meta-analysis: mortality and s ...... erapy for chronic hepatitis C.
@en
Meta-analysis: mortality and s ...... erapy for chronic hepatitis C.
@nl
type
label
Meta-analysis: mortality and s ...... erapy for chronic hepatitis C.
@ast
Meta-analysis: mortality and s ...... erapy for chronic hepatitis C.
@en
Meta-analysis: mortality and s ...... erapy for chronic hepatitis C.
@nl
prefLabel
Meta-analysis: mortality and s ...... erapy for chronic hepatitis C.
@ast
Meta-analysis: mortality and s ...... erapy for chronic hepatitis C.
@en
Meta-analysis: mortality and s ...... erapy for chronic hepatitis C.
@nl
P2093
P2860
P1476
Meta-analysis: mortality and s ...... herapy for chronic hepatitis C
@en
P2093
Haruhiko Yoshida
Masaya Sato
Takahiro Kishikawa
Tatsuya Minami
P2860
P304
P356
10.1007/S00535-012-0631-Y
P577
2012-07-12T00:00:00Z